This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks to Watch: Netflix, AT&T

NEW YORK ( TheStreet) -- Netflix (NFLX - Get Report) shares were tumbling 9.5% to $211.02 in premarket trading Friday after Starz announced it's ended contract renewal discussions with the high-flying DVD rental and content streaming company.

Finisar (FNSR) shares were surging 8.5% to $20.16 after the optical communications equipment maker topped earnings forecasts for its latest quarter by keeping a lid on operating expenses.

The Sunnyvale, Calif.-based company reported fiscal first-quarter non-GAAP profit of 21 cents a share vs. the average estimate of 18 cents a share.

Esterline Technologies (ESL) shares were dropping 7.9% to $67.97 after the aerospace and defense products company said it now expects full-year earnings of $4.45 to $4.55 a share vs. the average analyst estimate of $5.09.

The company reported third-quarter earnings of $1.21 a share, in line with expectations.

H&R Block (HRB) shares were plunging 7.4% to $14.05 after the tax preparation company reported first-quarter loss of 57 cents a share vs. the consensus target of loss of 39 cents a share.

Bank of America (BAC - Get Report) shares were losing 5.2% to $7.50 on a New York Times report that said the firm may be among a handful to be sued by the Federal Housing Finance Agency for misrepresenting the quality of mortgage securities they assembled and sold at the height of the housing bubble.

The report said the federal agency is seeking billions of dollars in compensation.

Valero Energy (VLO) has agreed to buy Murphy Oil (MUR) USA's Meraux, La. refinery and related logistics assets for $325 million, and inventories with an estimated value of $300 million.

Valero shares were falling 2.3% to $21.98 and Murphy Oil shares were down 1.3% to $52.86.

AstraZeneca (AZN - Get Report) shares were falling 1.7% to $45.90 after the drug company said its Crestor anti-cholesterol medicine failed to beat Pfizer's (PFE) Lipitor in a head-to-head clinical trial, dubbed Saturn.

Campbell Soup (CPB) shares were rising 1.4% to $32.30 after the company reported fourth-quarter profit of 43 cent a share, above the average analyst estimate of 38 cents a share.

Shares of AT&T (T - Get Report) were edging 0.3% lower to $28.20 on a Reuters report that said that the telecommunications company may have to sell up to 25% of T-Mobile's business to assuage U.S. antitrust regulators and save its $39 billion T-Mobile acquisition plan.

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

Related links:

Copyright 2011 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AZN $28.92 0.00%
T $38.91 0.00%
BAC $14.36 0.00%
ESL $67.78 0.00%
NFLX $91.54 0.00%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs